Want to join the conversation?
$ACET said that its subsidiary, Rising Pharmaceuticals, is launching an FDA-approved generic version of $GSK's Avodart (Dutasteride) Softgel Capsules 0.5 mg in the U.S. market. According to IMS Health, U.S. market for Dutasteride, which is used for the treatment of symptomatic BPH in men with enlarged prostate, is about $452MM.
$TWTR rolled out an iOS update Dec. 8 night that killed its famous "@" symbol. This lead to confusion among the iOS users when they tried it to reply to tweets.
$AAL is getting stronger into Dec. after a strong Nov..!! I’m feeling confident about their 4Q revenue forecast for a margin rise.